About Patel Chem Specialities Limited

Incorporated in 2008, Patel Chem Specialities Limited (PCSL) is a specialized manufacturer and exporter of pharmaceutical excipients and specialty chemicals. Its products play a critical role in the pharmaceutical, food, cosmetic, and industrial sectors, serving as binders, disintegrants, thickeners, stabilizers, and gelling agents.

PCSL operates two well-equipped manufacturing facilities located in Vatva (Ahmedabad) and Talod (Himmatnagar). These facilities follow stringent quality protocols and are certified with international standards such as US-DMF and GMP, ensuring consistency in large-scale production.

The company’s manufacturing unit spans 7,000 square yards, with an annual production capacity exceeding 7,200 MT of pharmaceutical excipients. The setup includes dedicated zones for storage, production, R&D, quality control, packaging, and warehousing.

PCSL has established a strong global footprint, supplying its products to regions including East Asia, Europe, the Middle East, North America, and Southeast Asia. Its focus on innovation and quality has positioned it as a trusted name in the global specialty chemicals industry.

Key Product Portfolio:

• Rheollose® (Sodium Carboxymethyl Cellulose): Thickener and stabilizer

• Disolwell® (Croscarmellose Sodium): Super disintegrant in oral formulations

• Swellcal® (Calcium Carboxymethyl Cellulose): Used in pharma as a disintegrant

• AmyloTab™ (Pregelatinized Starch): Enhances disintegration and dissolution in tablets

As of March 31, 2025, the company employs a team of 136 professionals supporting its operations and growth.

Who are the Promoters of Patel Chem Specialities IPO?

Bhupesh Patel, Anshu Patel, and Vini Patel are the promoters of the company. The promoters hold 95.13% of the pre-IPO capital

What are the Objects of Patel Chem Specialities IPO?

The Company proposes to utilize the Net Proceeds from Issue towards funding the following objects

• Funding capital expenditure requirement of the Company Rs. 43.14 Crore
  * General Corporate purposes and Issue expenses 

Patel Chem Specialities IPO IPO GMP grey market premium, review, Subscription, allotment, listing estimate

Patel Chem Specialities IPO Review by Paresh Gordhandas, CA & Research Analyst.

🔍 Chanakya’s Review – Patel Chem Specialities IPO

Patel Chem Specialities Limited (PCSL), incorporated in 2008, is a niche manufacturer and exporter of pharmaceutical excipients and specialty chemicals. Its products are critical inputs across multiple sectors—pharmaceuticals, food, cosmetics, and industrial applications—serving functions such as binding, thickening, gelling, and disintegration.

The company operates two advanced manufacturing facilities in Vatva (Ahmedabad) and Talod (Himmatnagar), both adhering to US-DMF and GMP-certified quality standards. These units support large-scale, high-quality production, enhancing the company’s global credibility.

In FY 2024–25, PCSL reported a net profit of ₹10.57 crore on a total revenue of ₹105.55 crore, reflecting steady performance. A detailed review of its financial statements shows no signs of inflated numbers or aggressive accounting adjustments.

At the upper end of the price band, the IPO is valued at a P/E ratio of 14.21, which appears reasonable given its consistent profitability and global presence.

---

Chanakya’s Take: May Apply — Suitable for investors with a medium to long-term horizon seeking exposure in the specialty chemicals segment.

Quicklinks

• Sahifund
• BigGaddi
• Research Reports
• Magajmari

Patel Chem Specialities IPO GMP

 
Patel Chem Specialities IPO review